Patents Assigned to Genesis Research & Development Corp. Ltd.
-
Publication number: 20050130263Abstract: Isolated polynucleotides encoding polypeptides expressed in bovine mammary gland tissue are provided, together with genetic constructs and host cells comprising such isolated polynucleotides. Methods for the use of such polynucleotides and polypeptides are also provided.Type: ApplicationFiled: July 9, 2003Publication date: June 16, 2005Applicants: GENESIS RESEARCH AND DEVELOPMENT CORP. LTD., AGRESEARCH LTD.Inventors: Ilkka Havukkala, Matthew Glenn, Murray Grigor, Adrian Molenaar
-
Publication number: 20040009490Abstract: Novel polynucleotides isolated from Lactobacillus rhamnosus, as well as oligonucleotide probes and primers, genetic constructs comprising the polynucleotides, biological materials, including plants, microorganisms and multicellular organisms incorporating the polynucleotides, polypeptides expressed by the polynucleotides, and methods for using the polynucleotides and polypeptides are disclosed.Type: ApplicationFiled: October 3, 2002Publication date: January 15, 2004Applicant: GENESIS RESEARCH AND DEVELOPMENT CORP. LTD.Inventors: Matthew Glenn, Ilkka J. Havukkala, Mark Lubbers, James Dekker
-
Publication number: 20030180751Abstract: Isolated polynucleotides encoding polypeptides active in lignin, fructan and tannin biosynthetic pathways are provided, together with expression vectors and host cells comprising such isolated polynucleotides. Methods for the use of such polynucleotides and polypeptides are also provided.Type: ApplicationFiled: November 7, 2002Publication date: September 25, 2003Applicant: GENESIS RESEARCH AND DEVELOPMENT CORP. LTD.Inventors: Jeroen Demmer, Richard L. Forster, John Bryan Gibson, Michael Andrew Shenk, Michael Geoffrey Norriss, Matthew Glenn, Keith Martin Saulsbury, Claire Hall
-
Publication number: 20030138905Abstract: Isolated polynucleotides encoding polypeptides expressed in bovine mammary gland tissue are provided, together with genetic constructs and host cells comprising such isolated polynucleotides. Methods for the use of such polynucleotides and polypeptides are also provided.Type: ApplicationFiled: October 2, 2002Publication date: July 24, 2003Applicant: GENESIS RESEARCH AND DEVELOPMENT CORP. LTD.Inventors: Ilkka J. Havukkala, Matthew Glenn, Murray R. Grigor, Adrian J. Molenaar
-
Publication number: 20030138822Abstract: Novel polynucleotides isolated from Lactobacillus rhamnosus, as well as probes and primers, genetic constructs comprising the polynucleotides, biological materials, including plants, microorganisms and multicellular organisms incorporating the polynucleotides, polypeptides expressed by the polynucleotides, and methods for using the polynucleotides and polypeptides are disclosed.Type: ApplicationFiled: November 5, 2002Publication date: July 24, 2003Applicant: GENESIS RESEARCH AND DEVELOPMENT CORP. LTD.Inventors: Matthew Glenn, Mark W. Lubbers, James Dekker
-
Patent number: 6596925Abstract: Novel isolated plant polynucleotide promoter sequences are provided, together with genetic constructs comprising such polynucleotides. Methods for using such constructs in modulating the transcription of DNA sequences of interest are also disclosed, together with transgenic plants comprising such constructs.Type: GrantFiled: June 20, 2000Date of Patent: July 22, 2003Assignees: Genesis Research & Development Corp. Ltd., Rubicon Forests Holdings Ltd.Inventors: J. Ranjan Perera, Clare Eagleton, Stephen J. Rice
-
Publication number: 20030091981Abstract: The present application relates to a functional assay for high-throughput screening and identification of plant genes involved in xylogenesis and secondary cell wall formation. The assay involves transforming Zinnia mesophyll cells in vitro under non-inducing or transdifferentiation-inducing conditions with DNA constructs comprising one or more polynucleotide sequences toa be tested and comparing the expression of the sequences in the non-induced and transdifferentiating cells. The assay is particularly useful for identifying promoters that are active in xylem and xylem-forming tissues and their transcriptional regulators.Type: ApplicationFiled: November 8, 2002Publication date: May 15, 2003Applicant: GENESIS RESEARCH AND DEVELOPMENT CORP. LTD.Inventors: Sathish Puthigae, Jonathan Phillips, Barry Flinn, James G. Murison
-
Patent number: 6544772Abstract: Novel polynucleotides isolated from Lactobacillus rhamnosus, as well as probes and primers, genetic constructs comprising the polynucleotides, biological materials, including plants, microorganisms and multicellular organisms incorporating the polynucleotides, polypeptides expressed by the polynucleotides, and methods for using the polynucleotides and polypeptides are disclosed.Type: GrantFiled: August 8, 2000Date of Patent: April 8, 2003Assignees: Genesis Research & Development Corp. Ltd, Via Lachia Bioscience (NZ) Ltd.Inventors: Matthew Glenn, Ilkka J. Havukkala, Leonard N. Bloksberg, Mark W. Lubbers, James Dekker, Anna C. Christensson, Ross Holland, Paul W. O'Toole, Julian R. Reid, Timothy Coolbear
-
Publication number: 20020169302Abstract: Isolated polynucleotides encoding polypeptides expressed in bovine mammary gland tissue are provided, together with genetic constructs and host cells comprising such isolated polynucleotides. Methods for the use of such polynucleotides and polypeptides are also provided.Type: ApplicationFiled: February 19, 2002Publication date: November 14, 2002Applicant: Genesis Research and Development Corp. Ltd.Inventors: Illka J. Havukkala, Matthew Glenn, Murray R. Grigor, Adrian J. Molenaar
-
Publication number: 20020164625Abstract: Isolated polynucleotides encoding histatin polypeptides expressed in bovine tissues, including mammary gland and paratoid salivary gland tissues, are provided, together with genetic constructs and host cells comprising such isolated polynucleotides. Methods for the use of such polynucleotides and polypeptides are also provided.Type: ApplicationFiled: February 19, 2002Publication date: November 7, 2002Applicant: Genesis Research and Development Corp. Ltd.Inventors: Matthew Glenn, Murray R. Grigor, Adrian J. Molenaar, Stephen R. Davis
-
Patent number: 6410720Abstract: The present invention provides polypeptides comprising an immunogenic portion of a M. vaccae soluble protein and DNA molecules encoding such polypeptides, together with methods for their use in the diagnosis and treatment of mycobacterial infection. Methods for enhancing the immune response to an antigen including administration of M. vaccae culture filtrate or delipidated M. vaccae cells are also provided.Type: GrantFiled: November 5, 1998Date of Patent: June 25, 2002Assignee: Genesis Research & Development Corp. Ltd.Inventors: Paul Tan, Jun Hiyama
-
Patent number: 6361776Abstract: Polypeptides and polynucleotides isolated from Mycobacterium vaccae are provided, together with compositions comprising such polypeptide and polynucleotides and methods for their use in the enhancement of immune responses to heterologous antigens.Type: GrantFiled: December 6, 1999Date of Patent: March 26, 2002Assignee: Genesis Research & Development Corp. Ltd.Inventor: Alain Delcayre
-
Patent number: 6358734Abstract: The present invention provides polypeptides comprising an immunogenic epitope of a M. vaccae protein, polynucleotides encoding such polypeptides, and fusion proteins comprising at least one such polypeptide, together with DNA constructs comprising at least one inventive polynucleotide. Compositions comprising such polypeptides, polynucleotides, fusion proteins and/or DNA constructs may be employed in the treatment of infectious diseases and immune disorders.Type: GrantFiled: November 29, 1999Date of Patent: March 19, 2002Assignee: Genesis Research & Development Corp. Ltd.Inventor: Alain Delcayre
-
Patent number: 6328978Abstract: Methods for the treatment of skin disorders, including psoriasis, atopic dermatitis, allergic contact dermatitis, alopecia areata and skin cancers are provided, such methods comprising administering a composition having antigenic and/or adjuvant properties. Compositions which may be usefully employed in the inventive methods include inactivated M. vaccae cells, delipidated and deglycolipidated M. vaccae cells, M. vaccae culture filtrate and compounds present in or derived therefrom, together with combinations of such compositions.Type: GrantFiled: June 2, 1999Date of Patent: December 11, 2001Assignee: Genesis Research & Development Corp. Ltd.Inventors: James D. Watson, Paul L. J. Tan, Ross Prestidge
-
Patent number: 6255559Abstract: Methods for producing genetically modified plants, particularly woody plants, and most particularly plants of the Eucalyptus and Pinus species, involve transformation of target plant material with a desired genetic construct and regeneration of the transformed plant material using an adventitious shoot bud system. The methods provide a high transformation efficiency and substantially reduce the duration of the transformation and regeneration protocols. Stem segments of a target plant are transformed using Agrobacterium-mediated techniques, and adventitious shoot buds are regenerated from the Agrobacterium-infected stem segments. Preferred culture media, including selection media, and improved plant culture techniques are disclosed.Type: GrantFiled: September 15, 1998Date of Patent: July 3, 2001Assignees: Genesis Research & Development Corp. Ltd., Fletcher Challenge Forests Ltd.Inventor: Kheng Tuan Cheah